Accelerated linear growth and advanced bone age in Sotos syndrome is not associated with abnormalities of collagen metabolism

Velidi H. Rao, Bruce Alan Buehler, G. Bradley Schaefer

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: To investigate whether the advanced bone age in Sotos syndrome is associated with alterations in type I collagen metabolism in bone. Design and methods: The metabolism of collagen was studied by analyzing the production, gene expression and degradation of type I collagen in dermal fibroblast strains from patients with Sotos syndrome and comparing them with fibroblasts from age-matched healthy subjects. Collagen production was determined as collagenase digestible radioactivity and collagen mRNA levels were measured by RT-PCR. Collagen degradation was assessed by specific collagenase assay and gelatin zymography. To determine the structural defects in type I collagen, the newly synthesized proteins were analyzed by SDS-PAGE before and after proteolytic digestion with pepsin. Results: In the present study, we have demonstrated that the collagen production, secretion and degradation in Sotos syndrome is comparable to controls. In addition, no qualitative differences in mRNA transcripts for type I collagen were detected between the control and Sotos syndrome fibroblasts. The secretion and intracellular accumulation of procollagen is also comparable to controls. The analysis of both procollagen and collagen on SDS-PAGE did not exhibit any major structural changes as compared with controls. Conclusions: Our results on several aspects of collagen metabolism have demonstrated for the first time that collagen, the most abundant of mammalian proteins and the major constituent of bone, is normal in patients with Sotos syndrome. Therefore, it appears that the advanced bone age and accelerated linear growth seen in patients with Sotos syndrome may not be attributed to inherent abnormalities of collagen metabolism. The etiology and the pathogenesis of Sotos syndrome still remains unclear.

Original languageEnglish (US)
Pages (from-to)241-249
Number of pages9
JournalClinical Biochemistry
Volume31
Issue number4
DOIs
StatePublished - Jun 1 1998

Fingerprint

Sotos Syndrome
Bone Development
Metabolism
Bone
Collagen
Collagen Type I
Fibroblasts
Bone and Bones
Procollagen
Collagenases
Degradation
Polyacrylamide Gel Electrophoresis
Messenger RNA
Pepsin A
Radioactivity
Gelatin
Gene expression
Digestion
Assays
Healthy Volunteers

Keywords

  • Collagen degradation
  • Collagen metabolism
  • Collagen production
  • Collagen turnover
  • Fibroblasts
  • Gene expression
  • RT-PCR
  • SDS- PAGE
  • Sotos syndrome
  • Type I collagen

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Accelerated linear growth and advanced bone age in Sotos syndrome is not associated with abnormalities of collagen metabolism. / Rao, Velidi H.; Buehler, Bruce Alan; Schaefer, G. Bradley.

In: Clinical Biochemistry, Vol. 31, No. 4, 01.06.1998, p. 241-249.

Research output: Contribution to journalArticle

Rao, Velidi H. ; Buehler, Bruce Alan ; Schaefer, G. Bradley. / Accelerated linear growth and advanced bone age in Sotos syndrome is not associated with abnormalities of collagen metabolism. In: Clinical Biochemistry. 1998 ; Vol. 31, No. 4. pp. 241-249.
@article{db8a10f98d03492e91eb15c43a2dcbab,
title = "Accelerated linear growth and advanced bone age in Sotos syndrome is not associated with abnormalities of collagen metabolism",
abstract = "Objectives: To investigate whether the advanced bone age in Sotos syndrome is associated with alterations in type I collagen metabolism in bone. Design and methods: The metabolism of collagen was studied by analyzing the production, gene expression and degradation of type I collagen in dermal fibroblast strains from patients with Sotos syndrome and comparing them with fibroblasts from age-matched healthy subjects. Collagen production was determined as collagenase digestible radioactivity and collagen mRNA levels were measured by RT-PCR. Collagen degradation was assessed by specific collagenase assay and gelatin zymography. To determine the structural defects in type I collagen, the newly synthesized proteins were analyzed by SDS-PAGE before and after proteolytic digestion with pepsin. Results: In the present study, we have demonstrated that the collagen production, secretion and degradation in Sotos syndrome is comparable to controls. In addition, no qualitative differences in mRNA transcripts for type I collagen were detected between the control and Sotos syndrome fibroblasts. The secretion and intracellular accumulation of procollagen is also comparable to controls. The analysis of both procollagen and collagen on SDS-PAGE did not exhibit any major structural changes as compared with controls. Conclusions: Our results on several aspects of collagen metabolism have demonstrated for the first time that collagen, the most abundant of mammalian proteins and the major constituent of bone, is normal in patients with Sotos syndrome. Therefore, it appears that the advanced bone age and accelerated linear growth seen in patients with Sotos syndrome may not be attributed to inherent abnormalities of collagen metabolism. The etiology and the pathogenesis of Sotos syndrome still remains unclear.",
keywords = "Collagen degradation, Collagen metabolism, Collagen production, Collagen turnover, Fibroblasts, Gene expression, RT-PCR, SDS- PAGE, Sotos syndrome, Type I collagen",
author = "Rao, {Velidi H.} and Buehler, {Bruce Alan} and Schaefer, {G. Bradley}",
year = "1998",
month = "6",
day = "1",
doi = "10.1016/S0009-9120(98)00023-X",
language = "English (US)",
volume = "31",
pages = "241--249",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Accelerated linear growth and advanced bone age in Sotos syndrome is not associated with abnormalities of collagen metabolism

AU - Rao, Velidi H.

AU - Buehler, Bruce Alan

AU - Schaefer, G. Bradley

PY - 1998/6/1

Y1 - 1998/6/1

N2 - Objectives: To investigate whether the advanced bone age in Sotos syndrome is associated with alterations in type I collagen metabolism in bone. Design and methods: The metabolism of collagen was studied by analyzing the production, gene expression and degradation of type I collagen in dermal fibroblast strains from patients with Sotos syndrome and comparing them with fibroblasts from age-matched healthy subjects. Collagen production was determined as collagenase digestible radioactivity and collagen mRNA levels were measured by RT-PCR. Collagen degradation was assessed by specific collagenase assay and gelatin zymography. To determine the structural defects in type I collagen, the newly synthesized proteins were analyzed by SDS-PAGE before and after proteolytic digestion with pepsin. Results: In the present study, we have demonstrated that the collagen production, secretion and degradation in Sotos syndrome is comparable to controls. In addition, no qualitative differences in mRNA transcripts for type I collagen were detected between the control and Sotos syndrome fibroblasts. The secretion and intracellular accumulation of procollagen is also comparable to controls. The analysis of both procollagen and collagen on SDS-PAGE did not exhibit any major structural changes as compared with controls. Conclusions: Our results on several aspects of collagen metabolism have demonstrated for the first time that collagen, the most abundant of mammalian proteins and the major constituent of bone, is normal in patients with Sotos syndrome. Therefore, it appears that the advanced bone age and accelerated linear growth seen in patients with Sotos syndrome may not be attributed to inherent abnormalities of collagen metabolism. The etiology and the pathogenesis of Sotos syndrome still remains unclear.

AB - Objectives: To investigate whether the advanced bone age in Sotos syndrome is associated with alterations in type I collagen metabolism in bone. Design and methods: The metabolism of collagen was studied by analyzing the production, gene expression and degradation of type I collagen in dermal fibroblast strains from patients with Sotos syndrome and comparing them with fibroblasts from age-matched healthy subjects. Collagen production was determined as collagenase digestible radioactivity and collagen mRNA levels were measured by RT-PCR. Collagen degradation was assessed by specific collagenase assay and gelatin zymography. To determine the structural defects in type I collagen, the newly synthesized proteins were analyzed by SDS-PAGE before and after proteolytic digestion with pepsin. Results: In the present study, we have demonstrated that the collagen production, secretion and degradation in Sotos syndrome is comparable to controls. In addition, no qualitative differences in mRNA transcripts for type I collagen were detected between the control and Sotos syndrome fibroblasts. The secretion and intracellular accumulation of procollagen is also comparable to controls. The analysis of both procollagen and collagen on SDS-PAGE did not exhibit any major structural changes as compared with controls. Conclusions: Our results on several aspects of collagen metabolism have demonstrated for the first time that collagen, the most abundant of mammalian proteins and the major constituent of bone, is normal in patients with Sotos syndrome. Therefore, it appears that the advanced bone age and accelerated linear growth seen in patients with Sotos syndrome may not be attributed to inherent abnormalities of collagen metabolism. The etiology and the pathogenesis of Sotos syndrome still remains unclear.

KW - Collagen degradation

KW - Collagen metabolism

KW - Collagen production

KW - Collagen turnover

KW - Fibroblasts

KW - Gene expression

KW - RT-PCR

KW - SDS- PAGE

KW - Sotos syndrome

KW - Type I collagen

UR - http://www.scopus.com/inward/record.url?scp=0032101633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032101633&partnerID=8YFLogxK

U2 - 10.1016/S0009-9120(98)00023-X

DO - 10.1016/S0009-9120(98)00023-X

M3 - Article

VL - 31

SP - 241

EP - 249

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 4

ER -